{"name":"Neurodegenerative Disease Research Inc","slug":"neurodegenerative-disease-research-inc","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMiugFBVV95cUxOeGY4NmxkS3ExODZ1Sk5VUDRVTnI4WWhLSVBpSVlldExUYXhPMnp0ZFMxZW02NGIwOEZIVmxvQ21mOUJ3UlpGUjNKMXF2cjloT1hCYnJzYU1qU2JMb1E0eWJERXQ2bGd2bDRpYVBJV21yakhZeEYtNkRSZTUxUDJTM3hNelliOHdyZVpYNlJla2pPTENsNFdoWU51d2tKTDZKZGkxNDY0czVqZnVVQ0FsYkhLN1RNSHZmVGc?oc=5","date":"2026-03-18","type":"trial","source":"Stock Titan","summary":"AI tool aims to cut months from Alzheimer’s data prep at ADPD 2026 - Stock Titan","headline":"AI tool aims to cut months from Alzheimer’s data prep at ADPD 2026","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiYkFVX3lxTFA3czdwNmR5WkQ5cHJ5eFkwNEZWYU5OVnBuVlpEcDdRMVF4bmRLbEJfU0NNTFdhczZVeXkyYmEzaHo4czFSNzFuV0ppZE9FdC1BMXpBb3c0RlB3VXV0YXJUOHhR?oc=5","date":"2026-01-19","type":"pipeline","source":"Labiotech.eu","summary":"10 promising biotechs racing toward a cure for ALS - Labiotech.eu","headline":"10 promising biotechs racing toward a cure for ALS","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMijwJBVV95cUxNR1dzWVFjbTNZR0NZdjN5ZFJuZVljUmkycjQ3Mzg2MnpIUTZKWURqdngtWGhyS1ZpVnpwTjVlZ1BBMGNoWGwyZmR1ZWpQQXhNX1lma0xVOWJaWkJsTnRjMTM2dzhacUJXZGp2MkFrODZwLXBqX1FIazlLc1J0UDdMTm1wWXFYREgxNGN5N056ZFdEM0xHWHNpTTM0Q1VLLUJROTllX3lBVFI1emJDbmJ0b1VjNGNpMi1sM2JCelZkTlZ4OUhNWDljWlpWcWtNN09UY1gwc3VPWEZlS1RoMzlWbzFlRnlDQ21WMzNyLVNkODRCTXZzcHA1dHBVQUJ0STBkVHRGWDlCXzNBbGpRSnZV?oc=5","date":"2025-12-08","type":"trial","source":"Business Wire","summary":"Arrowhead Pharmaceuticals Initiates Phase 1/2a Study of ARO-MAPT for the Treatment of Alzheimer’s Disease and Other Tauopathies - Business Wire","headline":"Arrowhead Pharmaceuticals Initiates Phase 1/2a Study of ARO-MAPT for the Treatment of Alzheimer’s Disease and Other Tauo","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiygJBVV95cUxNT2txZUI0WjBiZ3gwdFowY0tCaHgzdk9jUENrQnlMSGVFM21nWXgyZl92a2xTektPRW9kVlc3bFZkbTltQ0VLZmdlVEJqNXhHa1Q4aUx0WF9odTdxN3JYY3phemtoQ2ZULTViOWJ4SmM5QjdCQ1M5M19QQjNhVTUtd3FHYWpOaUZJT3dVMWVkTzJCN0pMVVJGNTRZRUt2WWI2Q3JfM0ZlTkl6WHRnZGZpTDB1Rm9EczdUaWxSeU12NjAzTlNpYVVWZzFNM20wdkU4QTRJM21kNXE2RzJXWWV1LUttRHljTkxjYndUamVQaW1qZENMbmJVdnJQNGR5M25DbENZWE9oR1JwY21wWnJmQ1RqY2R1UmFOV3Q4VGtwLUJ5bHFwdm0tLWpIQU1KMmRybUpEemtNLVFPWkQ2MUJOd0lfWUdBaTU1NUE?oc=5","date":"2025-12-04","type":"pipeline","source":"PR Newswire","summary":"SciNeuro Pharmaceuticals Announces $53 Million Financing to Further Advance Pipeline of Therapies for Neurodegenerative Diseases and Appointment of Chief Financial Officer - PR Newswire","headline":"SciNeuro Pharmaceuticals Announces $53 Million Financing to Further Advance Pipeline of Therapies for Neurodegenerative ","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMieEFVX3lxTE9QeXh5bTJ5X3FSajd5QmhCNnZtakVOUVdSY1Z2eV9aZUtRMnFKNExidHZqaXM3OW92Rjlac3BLZko1QW1EaHAzSzB1S0MwdlFaVkw3OTd5ZEEtemlqekttbjhqb2RXUFc2QjcxTGVGcUd0cmZadTR5SA?oc=5","date":"2025-11-25","type":"pipeline","source":"Labiotech.eu","summary":"11 neuroscience biotech companies you should know about - Labiotech.eu","headline":"11 neuroscience biotech companies you should know about","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi1wFBVV95cUxNa3RlUjZwVXpwN1pVT0VmYTNkVVlESlRxUU5zcmN3WFJGREtFY0Y3SkRVb2RHWENUVGRQVGRYcjVUTkU4Z0RITGRuQ1hQa1NvSkxJaENwR1FubWRTZ21SOVB1RjVKdTNwMERmMFdHaE9lR0xxWkU1WWxjQjNZYm5BT2pqbFJhU19reHBNbzNSQWtjOFVTZ3lpU3NLbUdUbXRxYllJZ3ByamswQmJ6TFpfSmoxMkJiNm5GdDFrVksyTHQ2cjFnTzJvWk9ZN09yWF9GYW5BOGNMUQ?oc=5","date":"2025-09-22","type":"pipeline","source":"BioSpace","summary":"JCR Pharmaceuticals and Alexion Achieve Milestone in Collaborative Neurodegenerative Disease Program - BioSpace","headline":"JCR Pharmaceuticals and Alexion Achieve Milestone in Collaborative Neurodegenerative Disease Program","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiuAFBVV95cUxOMklZYXhLVnpjZFRKVTBKTTZ6TFJWTzQyaEZFUWxlNVQxMy1EM3F6dWZvXzZRQnNES1dXZHgzUFZidHExSTRJN015cDNtMkd5bFpINnlSY0RFaHdLUkYwaGEtQWF5SGhvZlpvSDZGRzRXVDVselhNUUVJMjE0TTEtZzk4S2VfR19sTjJVWGFMei1KUzU2VkNnNF81WHhRTHBkODh0elZvSTZnUV95NUVZSXVJQXNEYTNt?oc=5","date":"2025-09-16","type":"pipeline","source":"Fierce Biotech","summary":"Thermo Fisher debuts multiplex protein panel for neurodegenerative disease research - Fierce Biotech","headline":"Thermo Fisher debuts multiplex protein panel for neurodegenerative disease research","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiyAFBVV95cUxQUEZLaWJZZEw5UWwxNnFzbVdvWU9XTE9vcUxUZ2dqajcwU3czY052RXY2NHhxSmc4VkYxYW5uN2prNGJuc2NjcldHdU56aVVyVTdvZ2RzRFVpRVp6WldHd0xzMElFMDZ1anZpYWw1MHhuQXhDZlF5Z2JlcENLZ0ZGMWtUYy1WekpqWHNBeDdFVGpaa3dnNXUtbkFIZ2x0V2p3QTlVNlVkUzRicUhJb3ZGOV9nMVdFejNSRG94aGR4eGE1RGwtVXhkaQ?oc=5","date":"2025-09-02","type":"deal","source":"Arrowhead Pharmaceuticals, Inc.","summary":"Arrowhead Pharmaceuticals and Novartis Enter into a Global License and Collaboration Agreement - Arrowhead Pharmaceuticals, Inc.","headline":"Arrowhead Pharmaceuticals and Novartis Enter into a Global License and Collaboration Agreement - Arrowhead Pharmaceutica","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMirgFBVV95cUxPT09WVlZKUHR2eXJOdXRIYnA4dm5LZVdYeW9YRUNhaUhhOVRySUtXOU5yVy1zX19LeS05Q05xNEFDSzM4cTJvZFVZQnFaanBIS2xPRGtyS3l0VzZwWEhLUFoyQVdOZXcwRFQ2SFF4bWEtdGwyWEw5R1VNWjNVVjVUNFJrZTZOUm1aUjVuWW0xNWlJNHp5dEJnR1N2cmlKMjFfRnVYWURxTTFUWUdoSGc?oc=5","date":"2025-05-27","type":"pipeline","source":"Investing News Network","summary":"Alzheimer’s Disease Treatment Stocks: 3 Biggest NASDAQ Companies - Investing News Network","headline":"Alzheimer’s Disease Treatment Stocks: 3 Biggest NASDAQ Companies","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiuwFBVV95cUxOTnFrUGJCOEhwSjNYdlJ0a0JtcjkzVHJUM0ZKTjJaVHNOVnREQlN0QjZQdXFSbFRhQ25DTUphdThoN3c1dmlnNkhha3NPUUVLa2FnaGFQTnBQQkVvZmxadXBqa3NiY3RmNFdyaE10OGxwOGZoQU90dF9YSUZkQy1FNGxGVmhRdl9Wei1hQnJ5d3g0N2VLNWpqZlJ5NnI4SjFVWE85em1uNzRVVkxjYWtvWXNVUkh6S0xTYnZj?oc=5","date":"2024-08-29","type":"pipeline","source":"Pharmaceutical Technology","summary":"Who are the leading innovators in neuro-degenerative disease therapies for the pharmaceutical industry? - Pharmaceutical Technology","headline":"Who are the leading innovators in neuro-degenerative disease therapies for the pharmaceutical industry?","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiX0FVX3lxTE53ZzFJSXVpaHlrdXcxV2RwWDBUbWZ2a0lPUHRoMmZxNHcxMFE2cC1feXU0YUYyQTR3dTBycVRKeDZCU0NlMG5LbHZzSU02cS1ZaWI5VGhmM2FBWDZON01J?oc=5","date":"2024-03-13","type":"pipeline","source":"nature.com","summary":"Translating basic research into medical advances - nature.com","headline":"Translating basic research into medical advances","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMikwFBVV95cUxPRlMzVjE0aUdMdUFBWm1BSk83Qm5mMUVyQVh4OTRxZzh5NjdRbk1hZGMyXzZIdm5HUFVtZkZOVTdHa1VtOHlZc0Z3STl2YzFIam5admJZcUFIeTRJSnBQOHlLYmdRdXRnMUQwbWJ6cktqeGU1RVE1YThRNm40ZDNHaURBTlBBVklJNWZhd2swTXgxVFE?oc=5","date":"2024-02-07","type":"pipeline","source":"Frontiers","summary":"Current Drug Repurposing Strategies for Rare Neurodegenerative Disorders - Frontiers","headline":"Current Drug Repurposing Strategies for Rare Neurodegenerative Disorders","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":2,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}